<?xml version="1.0" encoding="UTF-8"?>
<p>This trial assessed efficacy outcomes for pain, function, and global assessment according to the recommendations of a core domain set for outcome measurement in clinical trials of knee osteoarthritis [
 <xref rid="B29" ref-type="bibr">29</xref>, 
 <xref rid="B30" ref-type="bibr">30</xref>]. Outcome assessment was performed on a biweekly basis, that is, at the end of the one-week run-in phase (baseline) and at the end of Week 2 and Week 4 (
 <xref ref-type="fig" rid="fig1">Figure 1</xref>).
</p>
